Hydrocortisone Butyrate Ointment
Product Images NDC 68682-271

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrocortisone Butyrate (NDC 68682-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydrocortisone-butyrate-figure-1-hydrocortisone_butyrate_structure.jpg (Hydrocortisone Butyrate Ointment 1)

FDA Label Image

Image 01

Image 01
This is the product label for a medication called Hydrocortisone Butyrate Ointment 0.1%. The ointment is manufactured by Ferncale Laboratories, Inc. and distributed by Oceanside Pharmaceuticals, a division of Bausch Health US, LLC. The product is for topical use only and is not to be used for ophthalmic purposes. Each gram of the ointment contains a certain amount of hydrocortisone butyrate in a mineral oil and polyethylene base. The recommended dosage is to apply a thin layer to the affected areas 2 to 3 times daily, or as directed by a physician. The product should be kept out of reach of children and stored at a controlled temperature between 2° to 30°C (36° to 86°F).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.